Abstract

Alpha-synuclein pathology driven impairment in adult neurogenesis was proposed as a potential cause of, or at least contributor to, memory impairment observed in both patients and animal models of Parkinson’s disease (PD) and Dementia with Lewy Bodies (DLB). Mice overexpressing wild-type alpha-synuclein under the Thy-1 promoter (Thy1-aSyn, line 61) uniquely replicate early cognitive deficits together with multiple other characteristic motor and non-motor symptoms, alpha-synuclein pathology and dopamine loss. Here we report overt intracellular accumulation of phosphorylated alpha-synuclein in the hippocampus of these transgenic mice. To test whether this alters adult neurogenesis and total number of mature neurons, we employed immunohistochemistry and an unbiased stereology approach to quantify the distinct neural progenitor cells and neurons in the hippocampal granule cell layer and subgranular zone of 6 (prodromal stage) and 16-month (dopamine loss) old Thy1-aSyn mice. Surprisingly, we observed an increase in the number of early stage, i.e., Pax6 expressing, progenitors whereas the numbers of late stage, i.e., Tbr2 expressing, progenitors and neurons were not altered. Astroglia marker was increased in the hippocampus of transgenic mice, but this was not specific to the regions where adult neurogenesis takes place, arguing against a commitment of additional early stage progenitors to the astroglia lineage. Together, this uncovers a novel aspect of alpha-synuclein pathology in adult neurogenesis. Studying its mechanisms in Thy1-aSyn mice could lead to discovery of effective therapeutic interventions for cognitive dysfunction in PD and DLB.

Highlights

  • Parkinson’s disease (PD) is characterized by the presence of proteinaceous cytoplasmic inclusions termed Lewy bodies (LB), with alpha-synuclein (α-syn) as a main component (Spillantini et al, 1998)

  • Alpha-syn-associated pathology plays a major role in neurodegenerative processes in Dementia with Lewy Bodies (DLB) and multiple system atrophy (MSA), together with PD collectively known as synucleinopathies (McCann et al, 2014)

  • (Thy1-aSyn), which apparently progresses with age. This perturbation of adult neurogenesis does not culminate in significantly increased numbers of late stage neural progenitor cells (NPCs) or neurons

Read more

Summary

Introduction

Parkinson’s disease (PD) is characterized by the presence of proteinaceous cytoplasmic inclusions termed Lewy bodies (LB), with alpha-synuclein (α-syn) as a main component (Spillantini et al, 1998). Alpha-syn-associated pathology plays a major role in neurodegenerative processes in Dementia with Lewy Bodies (DLB) and multiple system atrophy (MSA), together with PD collectively known as synucleinopathies (McCann et al, 2014). Non-motor symptoms including dementia, cognitive dysfunction, sleep impairments and mood disorders correlate with LB pathology in different brain regions, including olfactory bulb, medulla, pons, and various cortical regions (Braak et al, 2003; Braak and Tredici, 2011; Pfeiffer, 2016). PD and DLB combined are a leading cause of neurodegenerative dementias, second only to Alzheimer’s disease (Vann Jones and O’Brien, 2014). Alpha-syn-associated pathology in cortical and hippocampal brain areas is likely involved, but the precise cellular substrates and mechanisms are still elusive (Francis, 2009; Liu et al, 2019)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.